VOLPI, SARA
 Distribuzione geografica
Continente #
AS - Asia 49
NA - Nord America 34
EU - Europa 23
SA - Sud America 19
AF - Africa 2
Totale 127
Nazione #
US - Stati Uniti d'America 32
SG - Singapore 22
BR - Brasile 14
HK - Hong Kong 8
VN - Vietnam 7
CN - Cina 6
DE - Germania 6
FI - Finlandia 6
RU - Federazione Russa 4
AR - Argentina 3
IT - Italia 3
TR - Turchia 3
AE - Emirati Arabi Uniti 1
AO - Angola 1
BE - Belgio 1
CA - Canada 1
CO - Colombia 1
EC - Ecuador 1
FR - Francia 1
IE - Irlanda 1
JO - Giordania 1
LT - Lituania 1
MA - Marocco 1
NI - Nicaragua 1
UZ - Uzbekistan 1
Totale 127
Città #
Singapore 12
Hong Kong 8
Ashburn 4
Helsinki 4
Ho Chi Minh City 4
Munich 3
Brescia 2
Buffalo 2
Chicago 2
Council Bluffs 2
Istanbul 2
Lappeenranta 2
Moscow 2
Newark 2
Shanghai 2
Amman 1
Annapolis 1
Banfield 1
Beijing 1
Berazategui 1
Biên Hòa 1
Brooklyn 1
Brussels 1
Buena Fe 1
Burlington 1
Campo Grande 1
Denver 1
Des Moines 1
Dublin 1
Elk Grove Village 1
Frankfurt am Main 1
Guaporé 1
Guarujá 1
Haiphong 1
Hamden 1
Hanoi 1
Itapuranga 1
Los Angeles 1
Luanda 1
Managua 1
New York 1
Niterói 1
Niğde 1
Nuremberg 1
Paraisópolis 1
Paulista 1
Phoenix 1
Piracicaba 1
Presidente Tancredo Neves 1
Rabat 1
Redondo Beach 1
Rosario 1
Rostov-on-Don 1
Sabará 1
Santa Clara 1
Saquarema 1
Sincelejo 1
Sombrio 1
Sumaré 1
Suzhou 1
São Vicente 1
Tashkent 1
Totale 100
Nome #
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 61
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 54
Improvement of patients reported outcomes and neurocognitive performances after Direct-Acting Antivirals: a longitudinal study 16
Totale 131
Categoria #
all - tutte 934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 1 0 0 0 0 0 0
2023/202418 0 1 3 1 1 1 1 0 6 0 2 2
2024/202549 0 0 1 6 2 6 9 2 5 3 9 6
2025/202663 8 15 10 17 13 0 0 0 0 0 0 0
Totale 131